Defense World
21 Mar 2026, 05:02 UTC · 33w ago
Definium Therapeutics Teases 3 Key DT-120 Data Readouts This Year, Highlights De-Risked Phase 3 Design
Verdict
Headline takes no side. We score DFTX +0.40 — moderately bullish.
- Expected · DFTX
+0.40moderately bullish
−1 bearish0bullish +1More positive than 69% of ticker scores this week
- Actual





